|
ENDO PHARMACEUTICALS HLDGS INC has added a news release to its Investor Relations website.
Title: Endo Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 1, 2010
Date(s): 20-Oct-2010 5:27 PM
For a complete listing of our news releases, please click here
CHADDS FORD, Pa., Oct 20, 2010 /PRNewswire via COMTEX/ --
Endo Pharmaceuticals (Nasdaq: ENDP) will announce its third quarter 2010 financial results on November 1, 2010 and will host a conference call and webcast at 10:00 a.m. ET that day to discuss these results.
David P. Holveck, president and CEO of Endo, Julie McHugh, chief operating officer, Dr. Ivan Gergel, executive vice president of R&D, Alan Levin, executive vice president and chief financial officer and Blaine Davis, vice president, corporate affairs will host the call.
Investors and other interested parties may call 866-788-0543 (domestic) or 857-350-1681 (international) and enter passcode 81013739. Please dial in 10 minutes prior to the scheduled start time.
A replay of the call will be available from November 1 at 1:00 p.m. ET until 12:00 a.m. ET on November 9 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering passcode 88788586.
|